The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)-Reference-Cited by-同舟云学术

The PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Published:2017-05-19 Issue:3 Volume:141 Page:594-603
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Balermpas Panagiotis¹²,Rödel Franz¹²,Krause Mechthild³⁴⁵⁶⁷,Linge Annett³⁴⁵⁷,Lohaus Fabian³⁴⁵⁷,Baumann Michael³⁴⁵⁶⁷,Tinhofer Inge⁸⁹,Budach Volker⁸⁹,Sak Ali¹⁰¹¹,Stuschke Martin¹⁰¹¹,Gkika Eleni¹²¹³,Grosu Anca-Ligia¹²¹³,Abdollahi Amir¹⁴¹⁵,Debus Jürgen¹⁴¹⁵,Stangl Stefan¹⁶,Ganswindt Ute¹⁶¹⁷,Belka Claus¹⁶¹⁷,Pigorsch Steffi¹⁶¹⁸,Multhoff Gabriele¹⁶¹⁸,Combs Stephanie E.¹⁶¹⁸,Welz Stefan¹⁹²⁰,Zips Daniel¹⁹²⁰,Lim Su Yin²¹,Rödel Claus¹²,Fokas Emmanouil¹²^ORCID,

Affiliation:

1. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Frankfurt Germany

2. Department of Radiotherapy and Oncology; Goethe-University Frankfurt; Frankfurt Germany

3. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Dresden Germany

4. Department of Radiation Oncology; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; Dresden Germany

5. OncoRay-National Center for Radiation Research in Oncology; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; Dresden Germany

6. Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology; Dresden Germany

7. National Institute for Tumor Diseases (NCT), Partner Site Dresden; Dresden Germany

8. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Berlin Germany

9. Department of Radiooncology and Radiotherapy; Charité-University Hospital Berlin; Berlin Germany

10. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Essen Germany

11. Department of Radiotherapy; Medical Faculty, University of Duisburg-Essen; Essen Germany

12. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Freiburg Germany

13. Department of Radiation Oncology; Medical Center, Faculty of Medicine, University of Freiburg; Freiburg Germany

14. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Heidelberg Germany

15. Department of Radiation Oncology; Heidelberg Ion Therapy Center (HIT), Heidelberg Institute of Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), University of Heidelberg Medical School and German Cancer Research Center (DKFZ); Heidelberg Germany

16. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Munich Germany

17. Department of Radiotherapy and Radiation Oncology; Ludwig-Maximilians-University; Munich Germany

18. Department of Radiation Oncology; Technical University Munich; , Munich Germany

19. German Cancer Research Center (DKFZ), Heidelberg, Germany and German Cancer Consortium (DKTK) partner sites; Tübingen Germany

20. Department of Radiation Oncology; Faculty of Medicine and University Hospital Tübingen, Eberhard Karls University Tübingen; Tübingen Germany

21. Department of Biomedical Sciences; Faculty of Medicine and Health Sciences, Macquarie University Sydney; Sydney NSW Australia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.30770/fullpdf

Reference48 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Human papillomavirus and rising oropharyngeal cancer incidence in the United States;Chaturvedi;J Clin Oncol,2011

3. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients;Castellsague;J Natl Cancer Inst,2016

4. Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence;Tinhofer;Eur J Cancer,2015

5. Human papillomavirus and survival of patients with oropharyngeal cancer;Ang;N Engl J Med,2010

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of HPV-associated cancers: From epidemiology to prevention;Pathology - Research and Practice;2024-11

2. Crosstalk between CAFs and tumour cells in head and neck cancer;Cell Death Discovery;2024-06-26

3. Type I conventional dendritic cells and CD8+ T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients;Frontiers in Immunology;2024-06-13

4. The molecular characteristics of recurrent/metastatic HPV‐positive head and neck squamous cell carcinoma: A systematic review of the literature;Clinical Otolaryngology;2024-04-24

5. The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers;Biomedicine & Pharmacotherapy;2024-02